Home › Funds › ArrowMark Colorado Holdings LLC › ABCL
ArrowMark Colorado Holdings LLC position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
ArrowMark Colorado Holdings LLC reported holding 4,105,095 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$32.2M, representing 1.34% of its reported portfolio and ranking #5 among its reported holdings. ArrowMark Colorado Holdings LLC has disclosed ABCL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ArrowMark Colorado Holdings LLC's ABCL position evolved
ArrowMark Colorado Holdings LLC first disclosed a stake in ABCL in Q3 2023 at 4,105,095 shares (US$18.9M). The position peaked in Q2 2026 at 4,105,095 shares, worth US$32.2M. Across 12 filings, ArrowMark Colorado Holdings LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 4,105,095 shares valued at US$32.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.11M | $18.88M | New |
| Q4 2023 | 4.11M | $23.44M | Hold |
| Q1 2024 | 4.11M | $18.60M | Hold |
| Q2 2024 | 4.11M | $12.15M | Hold |
| Q3 2024 | 4.11M | $10.67M | Hold |
| Q4 2024 | 4.11M | $12.03M | Hold |
| Q1 2025 | 4.11M | $9.15M | Hold |
| Q2 2025 | 4.11M | $14.08M | Hold |
| Q3 2025 | 4.11M | $20.65M | Hold |
| Q4 2025 | 4.11M | $14.04M | Hold |
| Q1 2026 | 4.11M | $14.33M | Hold |
| Q2 2026 | 4.11M | $32.22M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 37 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), Guardian Partners Inc. (US$8.7M), Intellectus Partners, LLC (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $259.15M · Q2 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 551.58K sh · $4.33M · Q2 2026
- SOFTBANK GROUP CORP. 345.16K sh · $2.71M · Q2 2026
More on ArrowMark Colorado Holdings LLC
FAQ
How long has ArrowMark Colorado Holdings LLC held ABCL?
ArrowMark Colorado Holdings LLC has disclosed ABCL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ArrowMark Colorado Holdings LLC's current position in ABCL?
As of Q2 2026, ArrowMark Colorado Holdings LLC holds 4.11M shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $32.22M, representing 1.34% of its reported portfolio and ranking #5.
Has ArrowMark Colorado Holdings LLC been buying or selling ABCL?
In the latest 13F filing (Q2 2026), ArrowMark Colorado Holdings LLC held unchanged its position in ABCL. The position peaked in Q2 2026 at 4.11M shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, Guardian Partners Inc., Intellectus Partners, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.